Cargando…
Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study
BACKGROUND: COVID-19 is a global public health problem causing high mortality worldwide. This study aimed to assess time to death and predictors of mortality among patients hospitalized for COVID-19 in the Arsi zone treatment center. METHOD: We performed a retrospective observational cohort study us...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084518/ https://www.ncbi.nlm.nih.gov/pubmed/35533178 http://dx.doi.org/10.1371/journal.pone.0268280 |
_version_ | 1784703628663062528 |
---|---|
author | Kaso, Abdene Weya Agero, Gebi Hurissa, Zewdu Kaso, Taha Ewune, Helen Ali Hareru, Habtamu Endashaw Hailu, Alemayehu |
author_facet | Kaso, Abdene Weya Agero, Gebi Hurissa, Zewdu Kaso, Taha Ewune, Helen Ali Hareru, Habtamu Endashaw Hailu, Alemayehu |
author_sort | Kaso, Abdene Weya |
collection | PubMed |
description | BACKGROUND: COVID-19 is a global public health problem causing high mortality worldwide. This study aimed to assess time to death and predictors of mortality among patients hospitalized for COVID-19 in the Arsi zone treatment center. METHOD: We performed a retrospective observational cohort study using medical records of laboratory-confirmed COVID-19 cases hospitalized at Bokoji Hospital COVID-19 treatment center from 1(st) July 2020 to 5(th) March 2021. We extracted data on the patients’ sociodemographic and clinical characteristics from medical records of hospitalized patients retrospectively. We carried out Kaplan Meier and Cox regression analysis to estimate survival probability and investigate predictors of COVID-19 death 5% level of significance. The Adjusted Hazard Ratio (aHR) with 95% Confidence Interval (CI) was estimated and interpreted for predictors of time to death in the final cox model. RESULT: A total of 422 COVID-19 patients treated were analyzed, of these more than one tenth (11.14%) deaths, with a mortality rate of 6.35 cases per 1000 person-days. The majority (87.2%) of deaths occurred within the first 14 days of admission, with a median time-to-death of nine (IQR: 8–12) days. We found patients that age between 31 and 45 years (aHR = 2.55; 95% CI: (1.03, 6.34), older than 46 years (aHR = 2.59 (1.27, 5.30), chronic obstructive pulmonary disease (aHR = 4.60, 95%CI: (2.37, 8.91), Chronic kidney disease (aHR = 5.58, 95%CI: (1.70, 18.37), HIV/AIDS (aHR = 3.66, 95%CI: (1.20, 11.10), admission to the Intensive care unit(aHR = 7.44, 95%CI: (1.82, 30.42), and being on intranasal oxygen care (aHR = 6.27, 95%CI: (2.75, 4.30) were independent risk factors increasing risk of death from COVID-19 disease than their counterparts. CONCLUSION: The risk of dying due to COVID-19 disease was higher among patients with HIV/AIDS, chronic obstructive pulmonary disease, and chronic kidney diseases. We also found that older people, those admitted to ICU, and patients who received intranasal oxygen care had a higher risk of dying due to COVID-19 disease. Therefore, close monitoring hospitalized patients that are old aged and those with comorbidities after hospitalization is crucial within the first ten days of admission. |
format | Online Article Text |
id | pubmed-9084518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90845182022-05-10 Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study Kaso, Abdene Weya Agero, Gebi Hurissa, Zewdu Kaso, Taha Ewune, Helen Ali Hareru, Habtamu Endashaw Hailu, Alemayehu PLoS One Research Article BACKGROUND: COVID-19 is a global public health problem causing high mortality worldwide. This study aimed to assess time to death and predictors of mortality among patients hospitalized for COVID-19 in the Arsi zone treatment center. METHOD: We performed a retrospective observational cohort study using medical records of laboratory-confirmed COVID-19 cases hospitalized at Bokoji Hospital COVID-19 treatment center from 1(st) July 2020 to 5(th) March 2021. We extracted data on the patients’ sociodemographic and clinical characteristics from medical records of hospitalized patients retrospectively. We carried out Kaplan Meier and Cox regression analysis to estimate survival probability and investigate predictors of COVID-19 death 5% level of significance. The Adjusted Hazard Ratio (aHR) with 95% Confidence Interval (CI) was estimated and interpreted for predictors of time to death in the final cox model. RESULT: A total of 422 COVID-19 patients treated were analyzed, of these more than one tenth (11.14%) deaths, with a mortality rate of 6.35 cases per 1000 person-days. The majority (87.2%) of deaths occurred within the first 14 days of admission, with a median time-to-death of nine (IQR: 8–12) days. We found patients that age between 31 and 45 years (aHR = 2.55; 95% CI: (1.03, 6.34), older than 46 years (aHR = 2.59 (1.27, 5.30), chronic obstructive pulmonary disease (aHR = 4.60, 95%CI: (2.37, 8.91), Chronic kidney disease (aHR = 5.58, 95%CI: (1.70, 18.37), HIV/AIDS (aHR = 3.66, 95%CI: (1.20, 11.10), admission to the Intensive care unit(aHR = 7.44, 95%CI: (1.82, 30.42), and being on intranasal oxygen care (aHR = 6.27, 95%CI: (2.75, 4.30) were independent risk factors increasing risk of death from COVID-19 disease than their counterparts. CONCLUSION: The risk of dying due to COVID-19 disease was higher among patients with HIV/AIDS, chronic obstructive pulmonary disease, and chronic kidney diseases. We also found that older people, those admitted to ICU, and patients who received intranasal oxygen care had a higher risk of dying due to COVID-19 disease. Therefore, close monitoring hospitalized patients that are old aged and those with comorbidities after hospitalization is crucial within the first ten days of admission. Public Library of Science 2022-05-09 /pmc/articles/PMC9084518/ /pubmed/35533178 http://dx.doi.org/10.1371/journal.pone.0268280 Text en © 2022 Kaso et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kaso, Abdene Weya Agero, Gebi Hurissa, Zewdu Kaso, Taha Ewune, Helen Ali Hareru, Habtamu Endashaw Hailu, Alemayehu Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study |
title | Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study |
title_full | Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study |
title_fullStr | Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study |
title_full_unstemmed | Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study |
title_short | Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study |
title_sort | survival analysis of covid-19 patients in ethiopia: a hospital-based study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084518/ https://www.ncbi.nlm.nih.gov/pubmed/35533178 http://dx.doi.org/10.1371/journal.pone.0268280 |
work_keys_str_mv | AT kasoabdeneweya survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy AT agerogebi survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy AT hurissazewdu survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy AT kasotaha survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy AT ewunehelenali survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy AT hareruhabtamuendashaw survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy AT hailualemayehu survivalanalysisofcovid19patientsinethiopiaahospitalbasedstudy |